Cannabis Market Sales Projections and Regulatory Insights
Cannabis market sales projections highlight a $2.6 billion annual figure for New York in 2026. The evolving cannabis regulatory landscape affects cannabinoid product availability. Clinicians must navigate these changes carefully to support patient care.
Texas Rule Change Could Wipe Out 70% of One Local Hemp Store’s Sales | kcentv.com
The texas hemp compliance formula now includes THCA, affecting hemp product legality and reducing local store sales by 70%. This change impacts patient access to hemp-derived products. Clinicians must understand these regulatory shifts to guide patients…
Cannabis Market Expansion and Public Health Insights
This article reviews cannabis market expansion and its clinical implications as of March 15, 2026. It highlights legal sales growth alongside public health concerns. Clinicians should monitor these trends for patient safety and regulatory compliance.
New Ohio Law Limits THC-Infused Drinks on Store Shelves
Ohio THC beverage restrictions are significantly limiting patient access to cannabis-infused drinks in retail settings. This law affects both recreational and medical cannabis consumers seeking alternative delivery methods. Patients may need counseling…
Cannabis Normalization Risks in 2026 Market and Health
Cannabis normalization risks are rising alongside expanding legal markets in 2026. This article reviews market trends and pediatric cannabis exposure concerns. Clinicians must address these public health challenges carefully.
Virginia Lawmakers Approve Bill To Begin Retail Marijuana Sales
Virginia cannabis retail sales have been approved, creating a regulated market for safer patient access. This new framework allows clinicians to counsel on tested products with known potency. Legal retail sales improve safety compared to unregulated…
Cannabis Compounds Fatty Liver Disease Research 2026
This CED Digest highlights cannabis compounds fatty liver disease research with 436 clinically relevant items. CBD and CBG show promise in reducing hepatic steatosis and improving metabolic markers. Clinicians gain evidence-based insights into…
Florida Supreme Court Refuses to Review Legalization Lawsuit
The Florida medical cannabis program remains intact as the Supreme Court refuses to review the legalization lawsuit. This decision preserves the state's medical-only cannabis framework. Clinicians must continue operating within existing regulatory…
Georgia House Passes Limited Medical Cannabis Expansion! – Blog
Georgia medical cannabis legislation has recently expanded, marking incremental progress in patient access. This legislation affects physicians and patients by broadening therapeutic options. Clinicians should monitor regulatory updates to understand the…
Georgia House Passes Bill to Expand Medical Cannabis Program
Georgia medical cannabis expansion will increase patient eligibility and require clinicians to update screening and dosing protocols. The new bill reflects evidence-based policy development. Providers should prepare for changes in clinical practice and…
